PAAZ Research

PAAZ continues to actively research and pursue the integration of psilocybin and other psychedelics into mental health care. The links to studies and articles found below focus on understanding the therapeutic potential of these substances in treating various mental health conditions such as depression, PTSD, and anxiety. Visit this page often to stay informed and up to date on efforts being made to change the landscape of mental health treatment and the options that are available to Arizonans.

The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting

ScienceDirect

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial
Trial of Psilocybin versus Escitalopram for Depression
Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial